Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly in the development of targeted cancer therapies. It exhibits potential in modulating signaling pathways involved in tumor growth and inflammation. Due to its structural features, it enhances binding affinity and selectivity toward specific protein targets, improving drug efficacy. Also explored in the design of central nervous system agents owing to its ability to cross the blood-brain barrier. Its derivatives are investigated for use in treating neurodegenerative diseases and psychiatric disorders.